Podcast: USP's Tina Morris on New Biologics Chapters

Oct 12, 2011
By PharmTech Editors
USP's Tina Morris on Biologics Standards

Vice-president for biologics and biotechnology, US Pharmacopeia's Tina Morris discusses plans for new monoclonal antibody chapters, a product-class approach, the need for industry input, efforts toward pharmacopeial harmonization, and more. Recorded LIVE at the USP 2011 Science and Standards Symposium, October 2011.
Interviewed by Angie Drakulich, senior managing editor.

Related podcast with USP's Matthew van Hook

Related podcast with Gillian Woollet